Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Embolism in thyrotoxic atrial fibrillation.

R W Yuen, D H Gutteridge, P L Thompson

    The Medical Journal of Australia
    |June 30, 1979
    PubMed
    Summary

    Thyrotoxicosis patients with atrial fibrillation face a high risk of embolic events, including systemic and pulmonary emboli. Anticoagulant therapy is recommended for all patients with thyrotoxic atrial fibrillation to prevent serious complications.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Common genetic variants do not predict recurrent events in coronary heart disease patients.

    BMC cardiovascular disorders·2022
    Same author

    Calcaneal quantitative ultrasound is associated with all-cause and cardiovascular disease mortality independent of hip bone mineral density.

    Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·2022
    Same author

    Nonlinear Ultrafast Spin Scattering in the Skyrmion Phase of Cu_{2}OSeO_{3}.

    Physical review letters·2017
    Same author

    Abstracts from Hydrocephalus 2016.

    Fluids and barriers of the CNS·2017
    Same author

    The effect of anaemia on hospital length of stay in lumbar decompression and fusion procedures.

    Journal of perioperative practice·2016
    Same author

    The effect of antenatal lifestyle advice for women who are overweight or obese on secondary measures of neonatal body composition: the LIMIT randomised trial.

    BJOG : an international journal of obstetrics and gynaecology·2016

    Area of Science:

    • Cardiology
    • Endocrinology
    • Internal Medicine

    Background:

    • Thyrotoxicosis, a condition of excess thyroid hormones, can lead to cardiovascular complications.
    • Atrial fibrillation is a known arrhythmia associated with various underlying health conditions.

    Purpose of the Study:

    • To investigate the incidence and outcomes of embolic disease in patients with thyrotoxicosis and concurrent atrial fibrillation.
    • To assess the clinical significance of embolic events in this specific patient population.

    Main Methods:

    • Retrospective analysis of 210 patients diagnosed with thyrotoxicosis.
    • Identification of patients with concomitant atrial fibrillation.
    • Documentation of embolic events (systemic and pulmonary) and patient outcomes.

    Main Results:

    • 10% of thyrotoxicosis patients (21 out of 210) presented with atrial fibrillation.
    • 24% of these patients (5 out of 21) experienced systemic embolic events, with three having multiple emboli and one fatality.
    • Two additional patients suffered pulmonary embolism.

    Conclusions:

    • Embolic disease is a significant and frequent complication in patients with thyrotoxic atrial fibrillation.
    • Anticoagulant therapy should be strongly considered for all patients diagnosed with thyrotoxic atrial fibrillation to mitigate embolic risks.

    Related Experiment Videos